Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Alltracel Pharmaceuticals Plc - Re Agreement

Abstract:
Alltracel Announces a NanopeuticsTM Product and Technology Development License Agreement with HemCon Medical Technologies to Serve the Military Market

Up front license fees and products expected to be on the market by 2008

Alltracel Pharmaceuticals Plc - Re Agreement

Dublin, Ireland and London, UK | Posted on July 19th, 2007

Alltracel Pharmaceuticals Plc., ("Alltracel", or "the Company"), (AIM:AP.L), the Healthcare Innovation Group focused on the Woundcare, Oral Care, Dermal Health and Cardiovascular Health markets, today announces its NanopeuticsTM subsidiary has signed a licensing agreement for its technology with HemCon Medical Technologies, Inc., the haemorrhage control market leaders in military markets.

Following the successful completion of product concept testing in the US and the Czech Republic in Q2 NanopeuticsTM has agreed a technology development agreement focused on Chitosan- based NanospiderTM technology for advanced woundcare applications in all relevant markets.

An undisclosed license payment is payable immediately and will develop into a royalty revenue model for the completed Chitosan-NanospiderTM products which are expected to reach the market by 2008.

Commenting on the announcement, Tony Richardson, Alltracel's Chief Executive Officer said;

"The NanopeuticsTM technology has been well received in the market place, and today's announcement that HemCon Medical have decided to license our technology underpins the full potential it offers. HemCon is the leading haemorrhage control company serving the military markets and we are excited that we will be working together with their team to bring the NanospiderTM technology to market by 2008."

####

About Alltracel Pharmaceuticals Plc.
Alltracel, (AIM: AP.L) ( http://www.alltracel.com ) the Healthcare Innovation Group is focused on taking proprietary technology from research right through to commercialisation in the global healthcare market.

Alltracel Pharmaceuticals Plc., ("Alltracel") was founded in 1996 and is a public company which listed on London's Alternative Investment Market in July 2001.

With corporate headquarters in Dublin, Ireland; Alltracel has a commercial office in London, England; R&D subsidiary in the Czech Republic and manufacturing facilities in Shenzhen, China. Alltracel also has a wide network of research, development and manufacturing partners in Europe, Asia and North America.

Alltracel operates via two main divisions Alltracel Healthcare Group and Alltracel Healthcare Technologies:

Alltracel Healthcare Group is focused on the commercialisation effort behind proven innovative technologies and services for the global healthcare market. Alltracel Healthcare Group has a range of stake holdings, joint ventures and wholly owned business units operating in a variety of healthcare categories including Wound Care, Oral Care, and Cardiovascular Health.

- Alltracel's specialist Oral Care subsidiary Westone ( http://www.westoneproducts.com ) is headquartered in London, England and is the leading contract supply and manufacturing partner for the European private label inter-dental market. Westone also partners with a number of leading oral care brands internationally.

- Alltracel's specialist Nanotechnology subsidiary Nanopeutics s.r.o. ( http://www.nanopeutics.net ) is headquartered in Liberec in the Czech Republic and is dedicated to the commercialisation of NanospiderTM technology for the global healthcare market.

Alltracel Healthcare Technologies specialises in innovation, research, development and the deployment of proprietary technology in the global healthcare market. Alltracel Healthcare Technologies has established a substantial intellectual property portfolio with patents in a number of healthcare applications areas such as Wound Care, Cardiovascular Health and Skin Care.

m-docTM & PhytopeuticsTM are trademarks of Alltracel Pharmaceuticals plc.

NanospiderTM and NanopeuticsTM are trademarks controlled by Nanopeutics s.r.o.

This information is provided by RNS
The company news service from the London Stock Exchange

For more information, please click here

Contacts:
Dublin: Karen Muldowney
Alltracel: +353 1 235 2162


London: Deborah Scott
Financial Dynamics: +44 207 831 3113

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanomedicine

Study reveals how herpes virus tricks the immune system February 5th, 2016

Hepatitis virus-like particles as potential cancer treatment February 5th, 2016

Researchers discover new phase of boron nitride and a new way to create pure c-BN February 5th, 2016

Nanoparticles Make Fertility Possible during Consumption of Anticancer Drugs February 4th, 2016

Announcements

Study reveals how herpes virus tricks the immune system February 5th, 2016

Hepatitis virus-like particles as potential cancer treatment February 5th, 2016

Organic crystals allow creating flexible electronic devices: The researchers from the Faculty of Physics of the Moscow State University have grown organic crystals that allow creating flexible electronic devices February 5th, 2016

Researchers discover new phase of boron nitride and a new way to create pure c-BN February 5th, 2016

Military

Scientists guide gold nanoparticles to form 'diamond' superlattices: DNA scaffolds cage and coax nanoparticles into position to form crystalline arrangements that mimic the atomic structure of diamond February 4th, 2016

Researchers develop completely new kind of polymer: Hybrid polymers could lead to new concepts in self-repairing materials, drug delivery and artificial muscles January 30th, 2016

Nano-coating makes coaxial cables lighter: Rice University scientists replace metal with carbon nanotubes for aerospace use January 28th, 2016

Scientists build a neural network using plastic memristors: A group of Russian and Italian scientists have created a neural network based on polymeric memristors -- devices that can potentially be used to build fundamentally new computers January 28th, 2016

New-Contracts/Sales/Customers

Heriot-Watt's Institute of Photonics & Quantum Sciences uses the Deben Microtest 2 kN tensile stage to characterise ceramics and engineering plastics January 21st, 2016

Industrial Nanotech, Inc. Begins Supplying One of World's Largest Pulp and Paper Product Companies with Patented Energy Saving and Protective Coatings for Heat Process Equipment January 4th, 2016

Industrial Nanotech, Inc. Announces Two More Offshore Oil and Gas Platform Projects December 9th, 2015

Nanotech Signs MOU with Leading European Manufacturer to Supply Optical Thin Film to the Banknote Market: Alliance Combines Technology and Production Capacity to Address High Volume Opportunities November 17th, 2015

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic